Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent manner
about
miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expressionParadoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer.Signaling events associated with gonadotropin releasing hormone-agonist-induced hormonal castration and its reversal in canines.
P2860
Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent manner
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@ast
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@en
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@nl
type
label
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@ast
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@en
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@nl
prefLabel
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@ast
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@en
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@nl
P2860
P50
P1433
P1476
Gonadotropin-releasing hormone ...... axel in a p53-dependent manner
@en
P2093
Paolo G V Martini
Patrizia Limonta
P2860
P304
P356
10.1371/JOURNAL.PONE.0093713
P407
P577
2014-01-01T00:00:00Z